Commentary on “The role of conventional pelvic floor reconstructive surgeries in obstructed defecation symptoms change: CARE and OPTIMAL trials sub-analysis of 2-year follow-up data”
Sign Up to like & getrecommendations! Published in 2020 at "International Urogynecology Journal"
DOI: 10.1007/s00192-020-04246-z
Abstract: This study [1] was aimed at addressing two main questions: is any conventional vaginal prolapse repair effective in curing obstructed defecation symptoms and is there evidence to suggest that a sacrocolpopexy will increase the risk… read more here.
Keywords: study; obstructed defecation; defecation symptoms; care ... See more keywords
Macular and Peripapillary OCTA Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data.
Sign Up to like & getrecommendations! Published in 2020 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2020.06.009
Abstract: PURPOSE To identify optical coherence tomography angiography (OCTA) derived vessel metrics of the macula and optic nerve head (ONH) that predict diabetic retinopathy (DR) disease progression. DESIGN Secondary analysis of clinical trial data METHODS: This… read more here.
Keywords: time study; diabetic retinopathy; analysis; octa metrics ... See more keywords
Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson’s Disease Patients with Motor Fluctuations
Sign Up to like & getrecommendations! Published in 2022 at "European Neurology"
DOI: 10.1159/000523771
Abstract: Introduction: The OPTIPARK study confirmed the effectiveness and safety of opicapone as adjunct therapy to levodopa in patients with Parkinson’s disease (PD) and motor fluctuations under real-world conditions. The aim of this sub-analysis was to… read more here.
Keywords: parkinson disease; clinical practice; sub analysis; motor fluctuations ... See more keywords
The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11030674
Abstract: Background: The effects of uric acid (UA)-lowering therapy with xanthine oxidoreductase (XOR) inhibitors on the development of cardiovascular diseases remain controversial. Based on recent findings that plasma XOR activity increased in liver disease conditions, we… read more here.
Keywords: beyond study; xanthine oxidoreductase; stiffness; arterial stiffness ... See more keywords
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Fungi"
DOI: 10.3390/jof9050569
Abstract: An altered gut microbiota is a possible contributing pathogenic factor in myasthenia gravis (MG), an autoimmune neuromuscular disease. However, the significance of the fungal microbiome is an understudied and neglected part of the intestinal microbiome… read more here.
Keywords: mybiom study; myasthenia gravis; analysis mybiom; microbiome ... See more keywords
Efficacy of a Coriolus versicolor-Based Vaginal Gel in Human Papillomavirus-Positive Women Older Than 40 Years: A Sub-Analysis of PALOMA Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12101559
Abstract: In the PALOMA trial, Papilocare® demonstrated efficacy in repairing low-grade cervical lesions related to human papillomavirus (HPV). This sub-analysis aimed to evaluate its efficacy in repairing these cervical lesions and clearing HPV in women aged… read more here.
Keywords: older years; hpv; efficacy; human papillomavirus ... See more keywords
Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Atherosclerosis and Thrombosis"
DOI: 10.5551/jat.56093
Abstract: Aims: The efficacy of antiplatelet therapy may vary among different disease subtypes. Prasugrel is generally a more potent, consistent, and fast-acting platelet inhibitor than clopidogrel. This sub-analysis of the phase III comparison of PRAsugrel and… read more here.
Keywords: trial; prasugrel; etiology; group ... See more keywords